- Home
- AMBA vs ZLAB Comparison
AMBA vs ZLAB Comparison
Compare AMBA & ZLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMBA
- ZLAB
- Stock Information
- Founded
- AMBA 2004
- ZLAB 2013
- Country
- AMBA United States
- ZLAB China
- Employees
- AMBA N/A
- ZLAB N/A
- Industry
- AMBA Semiconductors
- ZLAB Biotechnology: Pharmaceutical Preparations
- Sector
- AMBA Technology
- ZLAB Health Care
- Exchange
- AMBA Nasdaq
- ZLAB Nasdaq
- Market Cap
- AMBA 3.3B
- ZLAB 4.0B
- IPO Year
- AMBA N/A
- ZLAB 2017
- Fundamental
- Price
- AMBA $66.99
- ZLAB $35.73
- Analyst Decision
- AMBA Buy
- ZLAB Buy
- Analyst Count
- AMBA 11
- ZLAB 6
- Target Price
- AMBA $82.27
- ZLAB $57.22
- AVG Volume (30 Days)
- AMBA 502.6K
- ZLAB 761.4K
- Earning Date
- AMBA 08-28-2025
- ZLAB 08-07-2025
- Dividend Yield
- AMBA N/A
- ZLAB N/A
- EPS Growth
- AMBA N/A
- ZLAB N/A
- EPS
- AMBA N/A
- ZLAB N/A
- Revenue
- AMBA $316,264,000.00
- ZLAB $427,799,000.00
- Revenue This Year
- AMBA $25.21
- ZLAB $45.16
- Revenue Next Year
- AMBA $10.04
- ZLAB $56.81
- P/E Ratio
- AMBA N/A
- ZLAB N/A
- Revenue Growth
- AMBA 44.54
- ZLAB 32.56
- 52 Week Low
- AMBA $38.86
- ZLAB $16.03
- 52 Week High
- AMBA $85.15
- ZLAB $44.34
- Technical
- Relative Strength Index (RSI)
- AMBA 53.39
- ZLAB 48.57
- Support Level
- AMBA $61.31
- ZLAB $34.37
- Resistance Level
- AMBA $70.42
- ZLAB $35.83
- Average True Range (ATR)
- AMBA 2.61
- ZLAB 1.13
- MACD
- AMBA 0.06
- ZLAB -0.32
- Stochastic Oscillator
- AMBA 53.43
- ZLAB 31.88
About AMBA Ambarella Inc.
Ambarella Inc is a developer of semiconductor processing solutions for high-definition video capture, sharing, and display. The firm's solutions are sold to original design manufacturers and original equipment manufacturers to be designed for use in infrastructure broadcast encoders, wearable device cameras, automotive cameras, and security cameras. Ambarella's system-on-a-chip designs, based on its proprietary technology platform, are highly configurable to applications in various end markets. Geographical presence in Taiwan, Asia Pacific, Europe, North America, and the United States. The firm derives the majority of its revenue from Taiwan.
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.